Variant report
Variant | nsv461582 |
---|---|
Chromosome Location | chr4:91910883-91925784 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:91905983..91908591-chr4:91914277..91915974,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6849036 | chr4:91910883-91910884 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs6823287 | chr4:91910893-91910894 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs567842224 | chr4:91910906-91910907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182443186 | chr4:91910920-91910921 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187021950 | chr4:91910941-91910942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs17265766 | chr4:91910961-91910962 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs547904908 | chr4:91910983-91910984 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs566018525 | chr4:91910994-91910995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs201901205 | chr4:91911007-91911008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191050015 | chr4:91911042-91911043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572982491 | chr4:91911047-91911048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17265801 | chr4:91911048-91911049 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs562144546 | chr4:91911059-91911060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575782806 | chr4:91911120-91911121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544736444 | chr4:91911133-91911134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs182294963 | chr4:91911176-91911177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs533176996 | chr4:91911194-91911195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371075816 | chr4:91911196-91911197 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547269461 | chr4:91911207-91911208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560662702 | chr4:91911263-91911264 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529467152 | chr4:91911303-91911304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs17017894 | chr4:91911306-91911307 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs569122660 | chr4:91911320-91911321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs187329290 | chr4:91911401-91911402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs11727994 | chr4:91911417-91911418 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs570109182 | chr4:91911480-91911481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs17017898 | chr4:91911495-91911496 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs553214600 | chr4:91911506-91911507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573085909 | chr4:91911514-91911515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76760756 | chr4:91911519-91911520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11728122 | chr4:91911602-91911603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs17017905 | chr4:91911659-91911660 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs544671453 | chr4:91911672-91911673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558331479 | chr4:91911695-91911696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577961540 | chr4:91911708-91911709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs367571852 | chr4:91911733-91911734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540302947 | chr4:91911740-91911741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs17200097 | chr4:91911743-91911744 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs572165887 | chr4:91911809-91911810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs529525909 | chr4:91911847-91911848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542882270 | chr4:91911852-91911853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542921764 | chr4:91911877-91911878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs562692405 | chr4:91911906-91911907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531830300 | chr4:91911982-91911983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs190184840 | chr4:91912032-91912033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs570244004 | chr4:91912126-91912127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115133383 | chr4:91912127-91912128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs546254152 | chr4:91912134-91912135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566479476 | chr4:91912138-91912139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1381298 | chr4:91912155-91912156 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:91910000-91911800 | Enhancers | Fetal Lung | lung |
2 | chr4:91911000-91912000 | Enhancers | Fetal Heart | heart |
3 | chr4:91912000-91915800 | Weak transcription | Fetal Heart | heart |
4 | chr4:91912800-91913400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:91913000-91913400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr4:91915800-91916200 | Enhancers | Fetal Heart | heart |
7 | chr4:91915800-91916600 | Enhancers | Colon Smooth Muscle | Colon |
8 | chr4:91916000-91916400 | Enhancers | Fetal Kidney | kidney |
9 | chr4:91918200-91918400 | Enhancers | Colon Smooth Muscle | Colon |
10 | chr4:91918200-91918600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr4:91924400-91924800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr4:91924600-91924800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr4:91924800-91933400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |